Recurrent extramedullary plasmacytoma in asymptomatic multiple myeloma: a case report

por Schols, Saskia EM, Tick, Lidwine LW
Publicado 2015

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review

por Verhagen, Marieke J. A., Valke, Lars L. F. G., Schols, Saskia E. M.
Publicado 2022

Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case series

por Saes, Joline L., Laros‐van Gorkom, Britta A. P., Coppens, Michiel, Schols, Saskia E. M.
Publicado 2020

IRIDA Phenotype in TMPRSS6 Monoallelic-Affected Patients: Toward a Better Understanding of the Pathophysiology

por Hoving, Vera, Korman, Scott E., Antonopoulos, Petros, Donker, Albertine E., Schols, Saskia E. M., Swinkels, Dorine W.
Publicado 2022

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases

por Valke, Lars L. F. G., Rijpma, Sanna, Meijer, Danielle, Schols, Saskia E. M., van Heerde, Waander L.
Publicado 2022

Interaction of von Willebrand factor with blood cells in flow models: a systematic review

por Arisz, Ryanne A., de Vries, Judith J., Schols, Saskia E. M., Eikenboom, Jeroen C. J., de Maat,, Moniek P. M.
Publicado 2022

Diagnostic work up of patients with increased bleeding tendency

por Zegers, Suzanne A. M., Smit, Yolba, Saes, Joline L., van Duren, Clint, Schuijt, Tim J., van Heerde, Waander L., Schols, Saskia E. M.
Publicado 2019

Adherence to prophylaxis and its association with activation of self‐management and treatment satisfaction

por Hoefnagels, Johanna Wilhelmina, Schrijvers, Liesbeth Hélène, Leebeek, Frank W. G., Eikenboom, Jeroen, Schols, Saskia E. M., Smit, Cees, Schutgens, Roger E. G., Gouw, Samantha C., Fischer, Kathelijn
Publicado 2021

Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield

por Valke, Lars L. F. G., Meijer, Danielle, Nieuwenhuizen, Laurens, Laros‐van Gorkom, Britta A. P., Blijlevens, Nicole M. A., van Heerde, Waander L., Schols, Saskia E. M.
Publicado 2022

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency

por Saes, Joline L., Schols, Saskia E. M., Betbadal, Kathleen F., van Geffen, Mark, Verbeek‐Knobbe, Kitty, Gupta, Sweta, Hardesty, Brandon M., Shapiro, Amy D., van Heerde, Waander L.
Publicado 2019

Validation of the pedHAL(short) and HAL(short) in Dutch children and adults with haemophilia

por Kuijlaars, Isolde A. R., van der Net, Janjaap, van Vulpen, Lize F. D., Driessens, Mariette H. E., Schols, Saskia E. M., Tan, Melanie, Gouw, Samantha C., Fischer, Kathelijn
Publicado 2022

The potential of individualized dosing of ravulizumab to improve patient‐friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs

por ter Avest, Mendy, Langemeijer, Saskia M.C., Schols, Saskia E.M., Burger, David M., van de Kar, Nicole C.A.J., Blijlevens, Nicole M.A., Kievit, Wietske, ter Heine, Rob
Publicado 2021

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation

por Valke, Lars L.F.G., Bukkems, Laura H., Barteling, Wideke, Laros‐van Gorkom, Britta A.P., Blijlevens, Nicole M.A., Mathôt, Ron A.A., van Heerde, Waander L., Schols, Saskia E.M.
Publicado 2020

Patient‐reported outcomes in autosomal inherited bleeding disorders: A systematic literature review

por van Hoorn, Evelien S., Houwing, Maite E., Al Arashi, Wala, Leebeek, Frank W. G., Hazelzet, Jan A., Gouw, Samantha C., Schutgens, Roger E. G., Schols, Saskia E. M., Lingsma, Hester F., Cnossen, Marjon H.
Publicado 2022

Effect of Eculizumab on Iron Metabolism in Transfusion-independent Patients With Paroxysmal Nocturnal Hemoglobinuria

por Schaap, Charlotte C.M., Schols, Saskia E.M., Preijers, Frank W.M.B., de Jonge, Emiel, Laarakkers, Coby M.M., Jansen, Joop H., Blijlevens, Nicole M.A., Swinkels, Dorine W., Langemeijer, Saskia M.C.
Publicado 2023

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear

por Berny, Michelle A., Munnix, Imke C. A., Auger, Jocelyn M., Schols, Saskia E. M., Cosemans, Judith M. E. M., Panizzi, Peter, Bock, Paul E., Watson, Steve P., McCarty, Owen J. T., Heemskerk, Johan W. M.
Publicado 2010

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A

por Bukkems, Laura H., Valke, Lars L. F. G., Barteling, Wideke, Laros‐van Gorkom, Britta A. P., Blijlevens, Nicole M. A., Cnossen, Marjon H., van Heerde, Waander L., Schols, Saskia E. M., Mathôt, Ron A. A.
Publicado 2022

Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial

por van Vuren, Annelies, Kerkhoffs, Jean Louis, Schols, Saskia, Rijneveld, Anita, Nur, Erfan, Peereboom, Dore, Gandon, Yves, Welsing, Paco, van Wijk, Richard, Schutgens, Roger, van Solinge, Wouter, Marx, Joannes, Leiner, Tim, Biemond, Bart, van Beers, Eduard
Publicado 2022

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab

por Wijnsma, Kioa Lente, ter Heine, Rob, Moes, Dirk Jan A. R., Langemeijer, Saskia, Schols, Saskia E. M., Volokhina, Elena. B., van den Heuvel, Lambertus P., Wetzels, Jack F. M., van de Kar, Nicole C. A. J., Brüggemann, Roger J.
Publicado 2019

Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype

por Kempers, Eva K., van Kwawegen, Calvin B., de Meris, Joke, Schols, Saskia E. M., van Galen, Karin P. M., Meijer, Karina, Cnossen, Marjon H., van der Bom, Johanna G., Fijnvandraat, Karin, Eikenboom, Jeroen, Atiq, Ferdows, Leebeek, Frank W. G.
Publicado 2021